Nt-proBNP was analyzed with a commercially available chemiluminescence immunoassay on a Dimension Vista 1500, and amniotic fluid total protein concentration (AF-TP) by photometry on a Dimension RxL Max System (Siemens Healthcare Diagnostics, Eschborn, Germany). For nt-proBNP, inter- and intra-assay coefficients of variation were 3.5% and 2.3%, respectively. All samples were processed within two hours after retrieval.
Dimension rxl max system
Manufactured by Siemens
Sourced in Germany
The Dimension RxL Max System is a clinical chemistry analyzer designed for laboratory use. It is capable of performing a variety of in-vitro diagnostic tests to aid in the detection, diagnosis, and monitoring of medical conditions.
Automatically generated - may contain errors
Lab products found in correlation
5 protocols using dimension rxl max system
1
Biochemical Markers in Amniotic Fluid
2
Glycemic, Lipid, and Inflammatory Biomarkers
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Glycemic control was evaluated by HbA1c measurement, being accepted as the best indicator of recent integrated glycemic control and used in guiding clinical management [30 (link)]. HbA1c concentrations were determined by the Siemens Dimension® RxL Max® Integrated Chemistry System. The range of HbA1c levels for normal glucose tolerance in our population is 4–6%.
Lipid profile was assessed by measuring total cholesterol and triglycerides levels. Measurements were also done by the Siemens Dimension® RxL Max® System. Lipid status evaluation was performed at the study entry and repeated at the end of both phases, as presented inFigure 1 .
Bearing in mind that inflammation has been proposed as a common link between insulin resistance, obesity, diabetes and depression, we assessed inflammatory status in studied patients by CRP measurements, being a practicable and universally used global marker. For that purpose, CRP measurements were performed at the same checkpoints as lipid profile. CRP was measured using the Siemens Dimension® RxL Max® System. The cutoff for normal values in our population is <5 mg/L.
Lipid profile was assessed by measuring total cholesterol and triglycerides levels. Measurements were also done by the Siemens Dimension® RxL Max® System. Lipid status evaluation was performed at the study entry and repeated at the end of both phases, as presented in
Bearing in mind that inflammation has been proposed as a common link between insulin resistance, obesity, diabetes and depression, we assessed inflammatory status in studied patients by CRP measurements, being a practicable and universally used global marker. For that purpose, CRP measurements were performed at the same checkpoints as lipid profile. CRP was measured using the Siemens Dimension® RxL Max® System. The cutoff for normal values in our population is <5 mg/L.
3
Biomarker Measurement in Acute Myocardial Infarction
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood samples (3 mL) were taken from the femoral vein into clot activator tubes for serum total CK analysis and into lithium‐heparin tubes for analysis of plasma cTnI. Samples were prepared from blood by centrifugation separation. Total CK was measured by an enzymatic method, according to the manufacturer's recommendations, and cardiac TnI was assayed using an automated colorimetric immunoassay with reagents provided by the manufacturer. Both biomarkers were determined on a Dimension RxL Max system (Siemens Healthcare Diagnostics). Blood samples for biomarker measurement were obtained from a femoral vein at baseline (before AMI procedure), minute 0 (just before coronary occlusion), minute 60 (immediately before reperfusion), and every hour over 6 hours following reperfusion.
4
Urine Protein and Kidney Function Analysis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Urine protein output was measured by a BCA assay kit (FUJIFILM Wako Pure Chemical Co., Ltd., Osaka, Japan). Plasma BUN/plasma CRE, urine BUN/plasma BUN, and urine TP/urine CRE were calculated after measuring the BUN and CRE with a chemistry analyzer (Dimension RXL Max System, SIEMENS Co., Ltd., Tokyo, Japan).
5
Biochemical Markers in Amniotic Fluid
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Nt-proBNP was analyzed with a commercially available chemiluminescence immunoassay on a Dimension Vista 1500, and amniotic fluid total protein concentration (AF-TP) by photometry on a Dimension RxL Max System (Siemens Healthcare Diagnostics, Eschborn, Germany). For nt-proBNP, inter- and intra-assay coefficients of variation were 3.5% and 2.3%, respectively. All samples were processed within two hours after retrieval.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!